IRC
INSY

Investors Research Corp’s Insys Therapeutics, Inc. INSY Stock Holding History

Investors Research Corp’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,200
Closed -$10K – 1104
2019
Q1 		$10K Buy
+2,200
New +$10.4K 0.01% 799

Other funds holding INSY

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Investors Research Corp's INSY Position: Q2 2019 in Review

Investors Research Corp sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 2,200 shares — an estimated $10K sold.

Investors Research Corp first reported a position in INSY in Q1 2019 and held it in 1 quarter. The position peaked at $10K in Q1 2019. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • Investors Research Corp reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Investors Research Corp sold 2,200 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $10K.
  • Investors Research Corp first reported a position in Insys Therapeutics, Inc. in Q1 2019 and held it in 1 quarter.
  • Investors Research Corp's Insys Therapeutics, Inc. position peaked at $10K in Q1 2019.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Investors Research Corp's 13F filing for Q2 2019, filed 8 Jul 2019.